30 May 2017 | 5:07 PM
 

Parenteral Drugs (India) Ltd. Share Price Live (BSE)
0

BSE Code: 524689 | NSE Symbol: PDPL
23.00
-0.15
(-0.64 %)
30 May 2017 | 04:01 PM
Change company
  • Open (Rs)
    23.00
  • Prev. close (Rs.)
    23.15
  • High (Rs.)
    23.25
  • Low (Rs.)
    22.70
  • 52W H (Rs.)
    43.50
  • 52W L (Rs.)
    19.15
  • Volume (Rs.)
    1720
  • MCap (Rs in Cr.)
    68.58
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-39.09
Operating Margin (%)
-13.73
Gross Profit Margin (%)
-22.49
Net Profit Margin (%)
-44.77
Total Debt/Equity
13.33
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

31 Mar 2014 - 11:23:00-Parenteral Drugs India Ltd said that it has started production at its newly established arm Punjab F...
11 Nov 2013 - 12:48:00-Parenteral Drugs India Ltd said that the company has received Rs 99832668 from Mahaganpati Investmen...

Announcements

23-May-2017
Parenteral Drugs - Notice Of Board Meeting To Consider The Audited Financial Statements (Both Standalone And Consolidated) Fo
01-May-2017
Parenteral Drugs - Change in Directorate
21-Apr-2017
Parenteral Drugs - Shareholding for the Period Ended March 31 2017
18-Apr-2017
Parenteral Drugs - Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations
18-Apr-2017
Parenteral Drugs - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Reg

Religare Research

30 May 2017 | 11:40 AM
NRB Bearings reported in-line Q4FY17 numbers. Revenue and Net profit increased by 9.5% and 8.1% resp...
30 May 2017 | 11:03 AM
Incorporated in 1991, Srikalahasthi Pipes Ltd. (SPL; erstwhile Lanco Industries Ltd.) is one of the ...
30 May 2017 | 10:26 AM
Agri Fundamental and Technical report
30 May 2017 | 09:46 AM
• Gold little changed near 4-week highs in holiday-thinned trade • Oil edged up in quiet trade, focu...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors73.28%
Mutual Funds/UTI0.03%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others5.57%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,380.00(0.59)
3578
 Kovai Medical Center and Hospital Ltd.
1,230.00(-0.39)
11816
 Merck Ltd.
1,030.00(0.42)
3302
 AstraZeneca Pharma India Ltd.
924.00(0.22)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Parenteral Drugs (India) Ltd.-4.15-5.152.20
NIFTY(S&P CNX)310.75744.951,482.40
BSE SENSEX1,238.222,416.084,765.39
BSE 500151.65981.362,082.20

Corporate Details

Key Personal
Anil Mittal
WholeTime Director & CEO
Balkrishna V Chaubal
Nominee Director
Govind Das Garg
Whole Time Director
Key Address
Registered Office
340 Laxmi Plaza Laxmi Industrial Estate New Link Road Andheri (West),Mumbai,Maharashtra

Tel:022-61725900 66943547 26304940 26304941, Fax:022-61725901 26333763

cs.pdpl@pdindia.com
http://www.pdindia.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Parenteral Drugs (India) Ltd. that will help you decide whether to buy, sell or hold Parenteral Drugs (India) Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Parenteral Drugs (India) Ltd.